| No. |
Drug (Description in trials) |
DrugBank |
KEGG DRUG * |
KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
| 1 |
C03xa01 |
- |
- |
- |
- |
[2] 67, 72 |
| 2 |
Desmopressin |
Desmopressin |
D00291, D02235 |
[2] AVPR2, F8 |
[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
[5] 6, 64, 72, 225, 288 |
| 3 |
Desmopressin intranasal |
Desmopressin |
D00291, D02235 |
[2] AVPR2, F8 |
[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
[1] 72 |
| 4 |
Desmopressin oral melt |
Desmopressin |
D00291, D02235 |
[2] AVPR2, F8 |
[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
[1] 72 |
| 5 |
Empagliflozin |
Empagliflozin |
D10459 |
- |
- |
[2] 72, 257 |
| 6 |
Empagliflozin 25mg |
Empagliflozin |
D10459 |
- |
- |
[1] 72 |
| 7 |
Empagliflozin 25mg tbl |
Empagliflozin |
D10459 |
- |
- |
[1] 72 |
| 8 |
Iupac |
- |
- |
- |
- |
[1] 72 |
| 9 |
Samsca |
Tolvaptan |
D01213 |
[1] AVPR2 |
[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
[2] 67, 72 |
| 10 |
Samsca*10cpr 15mg |
Tolvaptan |
D01213 |
[1] AVPR2 |
[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
[1] 72 |
| 11 |
Satavaptan |
Satavaptan |
- |
- |
- |
[1] 72 |
| 12 |
Satavaptan (sr121463b) |
Satavaptan |
- |
- |
- |
[1] 72 |
| 13 |
Sr121463b |
- |
- |
- |
- |
[1] 72 |
| 14 |
Tolvaptan |
Tolvaptan |
D01213 |
[1] AVPR2 |
[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
[3] 67, 72, 225 |
| 15 |
Tolvaptan in euvolemic hyponatremia |
Tolvaptan |
D01213 |
[1] AVPR2 |
[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
[1] 72 |
| 16 |
Tolvaptan oral tablet |
Tolvaptan |
D01213 |
[1] AVPR2 |
[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
[1] 72 |